# Mesa Laboratories, Inc. (MLAB) stock: price and valuation

URL: https://funkfolio.com/stock/MLAB

> Mesa Laboratories, Inc. (MLAB) trades at $134.10, is worth $753.71M, is priced at 115.6× earnings and scores 48/100. Valuation, financials and signals.

---

## Mesa Laboratories, Inc. (MLAB)

Mesa Laboratories, Inc. (MLAB) is a technology company (scientific & technical instruments) based in the United States. The share price is $134.10, up 0.01% on the day, which values the company at $753.71M. Price as of 17 Nov 2026, 17:40 UTC, from Yahoo Finance.

### Key facts

- **Share price:** $134.10 +0.01% today
- **Market value:** $753.71M
- **P/E ratio:** 115.6× last 12 months
- **Forward P/E:** 11.0×
- **Dividend yield:** 0.48%
- **Funk Score:** 48/100
- **Against its own history:** Below its usual price usual price $162.30
- **200-week average:** $112.51 19% above

Figures as of 17 Nov 2026, 17:40 UTC. Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

### Mesa Laboratories, Inc. in more detail

MLAB trades at 115.6× its last twelve months' earnings, 11.0× next year's expected earnings, 3.0× sales. Measured against its own history, the price is 17% below what its usual multiples would imply ($162.30) — below its usual price. It sits 19% above its 200-week average of $112.51.

Over the last five fiscal years Mesa Laboratories, Inc. has compounded revenue 13.2% a year, earnings per share 13.6% a year, free cash flow 2.4% a year. Its Funk Score is 48 out of 100 (financial strength 3.0, profitability 5.2, growth 5.4, value 5.4, each out of 10).

In its favour: Strong Piotroski score. Worth checking: Share count keeps rising; Thin interest cover.

1 of the superinvestors tracked here hold MLAB, including Diamond Hill team (0.2% of the portfolio).

### Superinvestors holding MLAB

1 of the investors tracked here report a position in their latest 13F filing.

- [Diamond Hill team Diamond Hill Capital Management](https://funkfolio.com/gurus/diamond-hill) 0.18% of portfolio · $16.9M · trimmed · Q3 2026

### Mesa Laboratories, Inc. (MLAB): questions and answers

**What is MLAB's P/E ratio?**

Mesa Laboratories, Inc. trades at 115.6× its last twelve months' earnings and 11.0× next year's expected earnings. At its fiscal year-ends over the past 10 years the P/E ranged from 15.5× to 380.5×, with a median of 34.3×.

**What is Mesa Laboratories, Inc.'s market cap?**

Mesa Laboratories, Inc. is valued at $753.71M at a share price of $134.10.

**Is MLAB overvalued or undervalued?**

Against its own history, MLAB is below its usual price: the price is 17% below the $162.30 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

**Is MLAB above its 200-week moving average?**

Yes. MLAB is 19.2% above its 200-week average of $112.51. Long-term investors watch that line because strong companies rarely trade below it for long.

**How fast is Mesa Laboratories, Inc. growing?**

Over the last five fiscal years Mesa Laboratories, Inc.'s revenue grew 13.2% a year and its earnings per share 13.6% a year; over ten years revenue grew 11.4% a year.

**Does MLAB pay a dividend?**

Yes. Mesa Laboratories, Inc.'s dividend yield is 0.48%, or $0.64 a share a year, paying out 55% of earnings.

### Learn to read these numbers

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “Mesa Laboratories, Inc. (MLAB) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/MLAB

Underlying data: Yahoo Finance; company filings with the SEC.
